Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation

Cell Death and Differentiation

Volumn 19, Issue 9, 2012, Pages 1561-1570

  Boren, J ^a,b   Brindle, K M ^a,b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

apoptosis; fatty acid oxidation; lipid droplets; lipogenesis; ROS

Indexed keywords

7 AMINODACTINOMYCIN; FAT DROPLET; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FATTY ACID OXIDATION; LIPID STORAGE; LIPOGENESIS; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE; COENZYME A LIGASES; CYTOPLASM; FATTY ACIDS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84865199115     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.34     Document Type: Article

References (40)

1. Buchakjian MR, Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010; 11: 715-727.
2. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7: 606-619. (Pubitemid 44100518)
3. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107-120. (Pubitemid 44040989)
4. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci 2010; 107: 7455-7460.
5. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413-431.
6. Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 2010; 20: 427-434.
7. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117: 5479-5487. (Pubitemid 40012195)
8. Budanov AV, Karin M. P53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008; 134: 451-460.
9. Fu X, Wan S, Lyu YL, Liu LF, Qi H. Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 2008; 3: e2009.
10. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008; 8: 224-236.
11. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al. AMPK phosphorylation of Raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-226. (Pubitemid 351626684)
12. Ruderman NB, Saha AK, Kraegen EW. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 2003; 144: 5166-5171. (Pubitemid 37476042)
13. Blankenberg FG. In vivo detection of apoptosis. J Nucl Med 2008; 49: 81S-895.
14. Callies R, Sri-Pathmanathan RM, Ferguson DY, Brindle KM. The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magnet Resonan Med 1993; 29: 546-550. (Pubitemid 23112760)
15. Hakumaki JM, Kauppinen RA. 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci 2000; 25: 357-362. (Pubitemid 30497239)
16. Hakumaki JM, Poptani H, Sandmair A-M, Yla-Herttuala S, Kauppinen RA. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med 1999; 5: 1323-1327. (Pubitemid 29535613)
17. Quintero M, Cabañas ME, Arús C. 13C-labelling studies indicate compartmentalized synthesis of triacylglycerols in C6 rat glioma cells. Biochim Biophys Acta 2010; 1801: 693-701.
18. Iorio E, Di Vito M, Spadaro F, Ramoni C, Lococo E, Carnevale R et al. Triacsin C inhibits the formation of 1H NMR-visible mobile lipids and lipid bodies in HuT 78 apoptotic cells. Biochim Biophys Acta 2003; 1634: 1-14. (Pubitemid 37244049)
19. Delikatny EJ, Cooper WA, Brammah S, Sathasivam N, Rideout DC. Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. Cancer Res 2002; 62: 1394-1400. (Pubitemid 34407798)
20. Guo Y, Cordes KR, Farese Jr RV, Walther TC. Lipid droplets at a glance. J Cell Sci 2009; 122: 749-752.
21. Farese RV, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 2009; 139: 855-860.
22. Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, Chiang S-H et al. Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 2008; 283: 14355-14365.
23. Keij JF, Bell-Prince C, Steinkamp JA. Staining of mitochondrial membranes with 10-nonyl acridine orange MitoFluor Green, and MitoTracker Green is affected by mitochondrial membrane potential altering drugs. Cytometry 2000; 39: 203-210. (Pubitemid 30123854)
24. Scaduto RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1999; 76: 469-477. (Pubitemid 29202474)
25. Anthony ML, Zhao M, Brindle KM. Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J Biol Chem 1999; 274: 19686-19692.
26. Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y et al. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Cancer Sci 2009; 100: 1556-1562.
27. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 2006; 103: 10230-10235. (Pubitemid 44051149)
28. Witney TH, Kettunen MI, Day SE, Hu DE, Neves AA, Gallagher FA et al. A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. Neoplasia 2009; 11: 574-582.
29. Agius L, Meredith EJ, Sherratt HSA. Stereospecificity of the inhibition by etomoxir of fatty acid and cholesterol synthesis in isolated rat hepatocytes. Biochem Pharmacol 1991; 42: 1717-1720.
30. Liu K, Zhou S, Kim J-Y, Tillison K, Majors D, Rearick D et al. Functional analysis of FSP27 protein regions for lipid droplet localization, caspase-dependent apoptosis, and dimerization with CIDEA. Am J Physiol Endocrinol Metab 2009; 297: E1395-E1413.
31. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009; 461: 109-113.
32. Skulachev V. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 2006; 11: 473-485.
33. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells. J Biol Chem 2001; 276: 4588-4596.
34. Smith RAJ, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999; 263: 709-716. (Pubitemid 29361943)
35. Korge P, Weiss JN. Redox regulation of endogenous substrate oxidation by cardiac mitochondria. Am J Physiol Heart Circ Physiol 2006; 291: H1436-H1445. (Pubitemid 44343691)
36. Hurd TR, Prime TA, Harbour ME, Lilley KS, Murphy MP. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis. J Biol Chem 2007; 282: 22040-22051. (Pubitemid 47195755)
37. Henique C, Mansouri A, Fumey G, Lenoir V, Girard J, Bouillaud F et al. Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J Biol Chem 2010; 285: 36818-36827.
38. Choi S-E, Jung I-R, Lee Y-J, Lee S-J, Lee J-H, Kim Y et al. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death. Endocrinology 2011; 152: 816-827.
39. Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR et al. PPAR-[delta] senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 2009; 15: 1266-1272.
40. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005; 8: 311-321. (Pubitemid 41443416)